We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFGC icon
1026
Performance Food Group
PFGC
$18.4B
$372K ﹤0.01%
4,742
+599
+14% +$42K
TTC icon
1027
Toro Company
TTC
$8.86B
$371K ﹤0.01%
4,282
+662
+18% +$59.5K
NSSC icon
1028
Napco Security Technologies
NSSC
$1.31B
$371K ﹤0.01%
9,165
+1,165
+15% +$57.1K
CUZ icon
1029
Cousins Properties
CUZ
$5.38B
$370K ﹤0.01%
12,543
+3,171
+34% +$85.4K
IVZ icon
1030
Invesco
IVZ
$12.6B
$370K ﹤0.01%
21,046
+359
+2% +$5.89K
INGN icon
1031
Inogen
INGN
$176M
$369K ﹤0.01%
38,010
– –
AXS icon
1032
AXIS Capital
AXS
$7.75B
$367K ﹤0.01%
4,612
-368
-7% -$27.6K
WPC icon
1033
W.P. Carey
WPC
$16.6B
$363K ﹤0.01%
5,832
-162
-3% -$9.6K
TXRH icon
1034
Texas Roadhouse
TXRH
$13.8B
$362K ﹤0.01%
2,048
+375
+22% +$63.3K
WLY icon
1035
John Wiley & Sons Class A
WLY
$2.86B
$361K ﹤0.01%
7,489
+2,139
+40% +$98.2K
LWLG icon
1036
Lightwave Logic
LWLG
$892M
$361K ﹤0.01%
130,833
-366
-0.3% -$1.1K
LNC icon
1037
Lincoln National
LNC
$8.06B
$361K ﹤0.01%
11,452
-262
-2% -$8.17K
WBA
1038
DELISTED
Walgreens Boots Alliance
WBA
$361K ﹤0.01%
40,268
+18,199
+82% +$187K
AVT icon
1039
Avnet
AVT
$7.09B
$361K ﹤0.01%
6,642
+91
+1% +$4.79K
DOC icon
1040
Healthpeak Properties
DOC
$15.5B
$359K ﹤0.01%
15,687
-1,209
-7% -$26.1K
AOS icon
1041
A.O. Smith
AOS
$8.55B
$359K ﹤0.01%
3,992
+163
+4% +$13.5K
EGP icon
1042
EastGroup Properties
EGP
$11.3B
$358K ﹤0.01%
1,916
+499
+35% +$92K
IDEV icon
1043
iShares Core MSCI International Developed Markets ETF
IDEV
$31.5B
$354K ﹤0.01%
5,000
– –
NCLH icon
1044
Norwegian Cruise Line
NCLH
$9.75B
$353K ﹤0.01%
17,201
+1,381
+9% +$25.1K
PLMR icon
1045
Palomar
PLMR
$3.78B
$352K ﹤0.01%
+3,718
New +$343K
CYBR
1046
DELISTED
CyberArk
CYBR
$351K ﹤0.01%
1,205
-5
-0.4% -$1.35K
BIO icon
1047
Bio-Rad Laboratories Class A
BIO
$8.77B
$351K ﹤0.01%
+1,050
New +$333K
UHS icon
1048
Universal Health Services
UHS
$10.2B
$351K ﹤0.01%
1,532
+49
+3% +$10.6K
MFG icon
1049
Mizuho Financial
MFG
$122B
$349K ﹤0.01%
83,601
+9,281
+12% +$38.8K
APGE icon
1050
Apogee Therapeutics
APGE
$10.2B
$348K ﹤0.01%
5,923
-137
-2% -$6.56K
40 41
42
43 44

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.